Abstract
Objectives: To analyze the predictive value of cardiac collagen metabolism “in vivo" in patients with myocardial infarction (MI) treated with percutaneous coronary intervention (PCI). Design: Forty-five patients (age 66 ± 8.27) underwent biochemical analysis for cardiac collagen metabolism (groups A, B and C); 30 patients with their first MI were treated with successful PCI (group A; n = 30), group B (n = 5) were MI patients with unsuccessful PCI. Group C were patients without MI (n = 10), they underwent elective diagnostic coronary angiography only. The collagen metabolism was analyzed in acute and subacute MI phases by using serum blood markers: the carboxy-terminal propeptide of type I procollagen (PICP), amino-terminal propeptide of type III procollagen (PIIINP) and carboxy-terminal telopeptide of type I collagen (ICTP). Furthermore, the ejection fraction (EF) and left ventricular end-diastolic volume maximal changes in the course of 6 months were measured by echocardiography. Results: A significant increase of both PICP and PIIINP on day 4 following MI was detected. Furthermore, PICP and PIIINP level assessed on the 30th day was significantly higher in the PCI unsuccessful group versus successful group. PICP level on day 4 above 110 ug/l and PIIINP level above 4 ug/l was significantly often found in the subgroup of patients with the EF improvement less than 10% or worsening and with significant left ventricular dilatation during 6 months follow-up. Cardiac catheterization itself does not affect collagen metabolism. Conclusion: We concluded that collagen metabolism markers enable to study in vivo the MI healing and to predict left ventricular functional and volume changes.
Similar content being viewed by others
References
Pelouch V, Dixon IMC, Golfman L, Beamish RE, Dhalla NS: Role of extracellular proteins matrix in heart function. Mol Cell Biochem 129: 101–120, 1993
Pelouch V, Dixon IMC, Sethi R, Dhalla NS: Alteration of collagenous profile in congestive heart failure secondary to myocardial infarction. Mol Cell Biochem 129: 121–131, 1993
Cleutjens JP, Verleuyten MJ, Smiths JF, Daemen MJ: Collagen remodeling after myocardial infarction in rat heart. Am J Pathol 147: 325–338, 1995
Dhalla NS, Kaura D, Liu X, Beamish RE: Mechanisms of subcellular remodelling in post-infarct heart failure. EXS 76: 463–477, 1996
Wei S, Chow LT, Shum IO, Qin L, Sanderson JE: Left and right ventricular collagen type I/III rations and remodelling post-myocardial infarction. J Card Fail 5: 117–126, 1999
Paul S: Ventricular remodeling. Crit Care Nurs Clin North Am 15: 407–411, 2003
Delcayre C, Swynghedauw B: Molecular mechanisms of myocardial remodelling. The role of aldosterone. J Mol Cell Cardiol 34: 1577–1584, 2002
Freed DH, Moon MC, Borowiec AM, Jones SC, Zahradka P, Dixon I: Cardiotrophin — I: Expression in experimental myocardial infarction and potencial role in post — MI wound healing. Mol Cell Biochem 254: 247–256, 2003.
Janitcki JS, Brower GL, Gardner JD, Chancey AL, Steward JA, Jr: The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodelling. Heart Fail Rev 9: 33–42, 2004
Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA, Li X: Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110: 3221–3228, 2004
Whittaker P, Boughner DR, Kloner RA: Role of collagen in acute myocardial infarct expansion. Circulation 84: 2123–2134, 1991
Whittaker P, Kloner RA, Boughner DR, Pickering JG: Quantitative assessment of myocardial collagen with pictosirius red staining and circularly polarized light. Basic Res Cardiol 89: 397–410, 1994
Jirmar R, Pelouch V, Andel M, et al.: The relationship of collagen composition to left ventricular function and aneurysm formation after myocardial infarction. Cor Vasa 40(7): 340–346, 1998
Poulsen SH, Host NB, Jensen SE, et al.: Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation 101: 1527–1532, 2000
Halkin A, Aymong E, Cox DA, et al.: Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial). Am J Cardiol 93(3): 349–353, 2004
Jensen LT, Horst NB: Collagen: scaffold for repair or execution. Cardioavsc Res 33: 535–549, 1997
Poulsen SH, Host NB, Egstrup K: Long-term changes in collagen formation expressed by serum carboxyterminal propeptide of type I procollagen and relation to left ventricular function after acute myocardial infarction. Cardiology 96: 45–50, 2001
Hosgor I, Zarat A, Zlmazer S, Girisken G, Ahmad S: Collagen deposition in myocardium after inhibition of fibrinolytic activity. Blood Coagul Fibrinolysis 16: 25–30, 2005
Jirmar R, Pelouch V: The role of myocardial interstitium in the left ventricular emodeling after an acute myocardial infarction. Cor Vasa 35: 206–209, 1993
Jirmar R, Pelouch V, Widimsky P: Biochemical markers of collagen metabolism in patients with acute myocardial infarction. Another prognostic marker? (in Czech — English Summary). Cor Vasa 45: 592–595, 2003
Querejeta R, Lopez B, Gonzales A, Sanchez E, Larman M, Martinez UJL, Diez J: Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110: 1263–1268, 2004
Pelouch V, Jirmar R: Biochemical characteristics of cardiac collagen and its role in ventricular remodeling following infarction. Physiol Res 42: 283–292, 1993
Chen K, Li D, Zhang X, Hermonat PL, Mehta JL: Anoxia-reoxygenation stimulates collagen type I and MMP—1 expression in cardiac fibroblasts: Modulation by the PPAR-gamma ligand pioglitazone. J Cardiovasc Pharmacol 44: 682–687, 2004
Lopez B, Gonzales A, Varo N, Laviades C, Querejete R, Diez J: Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38: 1222–1226, 2001
Antman EM, Tanasijevic MJ, Thomson B: Cardiac specific troponin I levels to predict the risk of mortality in-patient with acute coronary syndromes. N Engl J Med 335: 1342–1349, 1996
Vatner SF, Heyndrickx GR, Fallon JT: Effects of brief periods of myocardial ischemia on regional myocardial function and creatine kinase release in conscious dogs and baboons. Can J Cardiol Suppl A: 19A–24A, 1986
Heyndrickx GR, Amano J, Kenna T, et al.: Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 6(6): 1299–1303, 1985
Cicoira M, Rossi A, Bonapace S, Zanolla L, Golia G, Franceschini L, Caruso B, Marino PN, Zardini P: Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulation levels in patients with chronic heart failure. J Card Fail 10: 403–411, 2004
Host NB, Jensen LT, Bendixen PM, Koldkjaer OG, Simon EE: The aminotherminal peptide of type III procollagen provided new information on prognosis after acute myocardial infarction. Am J Cardiol 76: 869–873, 1995
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Radovan, J., Vaclav, P., Petr, W. et al. Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction. Mol Cell Biochem 293, 71–78 (2006). https://doi.org/10.1007/s11010-006-2955-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-006-2955-5